Novo Holdings A/S - Significant Ownership

Signature - Title
/s/ Barbara Fiorini - Novo Holdings A/S By Barbara Fiorini, General Counsel, Finance & Operations
Location
Hellerup, Denmark
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Novo Holdings A/S.

Significant Ownership of Novo Holdings A/S

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
MAPLIGHT THERAPEUTICS, INC. Voting Common Stock, par value $0.0001 per share 8.4% 3.69M Novo Holdings A/S Oct 28, 2025
IOBT IO Biotech, Inc. Common Stock, par value $0.001 per share 7.3% $7.87M 4.98M Novo Holdings A/S Aug 11, 2025
FDMT 4D MOLECULAR THERAPEUTICS, INC. Common Stock, par value $0.0001 per share 6.8% $27.6M 3.18M Novo Holdings A/S Oct 13, 2025
EVO Evotec SE Ordinary Shares, no par value per share 5.3% $34.1M 9.41M Novo Holdings A/S Sep 30, 2025
ArriVent BioPharma, Inc. Common Stock, par value $0.0001 per share 4.9% 1.87M +6.98% Novo Holdings A/S Jun 30, 2025
ZBIO Zenas BioPharma, Inc. Common Stock, par value $0.0001 4.7% $44.4M -$4.77M 2M -9.71% Novo Holdings A/S Sep 30, 2025
GLTO Galecto, Inc. Common Stock, par value $0.00001 per share 0% 0 -100% Novo Holdings A/S Oct 7, 2025

Schedules 13D/G Reported by Novo Holdings A/S:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.